Nation-wide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients: Final report

European Neurology

Volumn 32, Issue , 1992, Pages 9-22

  Nakanishia, Takao ^a   Iwata, Makoto ^b   Golo, Ikuo ^c   Kanazawa, Ichiro ^b   Kowa, Hisayuki ^d   Mannen, Tohru ^e   Mizuno, Yoshikuni ^f   Nishitani, Hiroshi ^g   Ogawa, Norio ^h   Takahashi, Akira ⁱ   Tashiro, Kunio ^j   Tohgi, Hideo ^k   Yanagisawa, Nobuo ^l  

^a Mishuku Hospital   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d KITASATO UNIVERSITY HOSPITAL   (Japan)

^e MITSUI MEMORIAL HOSPITAL   (Japan)

^f JUNTENDO UNIVERSITY   (Japan)

^g UTANO NATIONAL HOSPITAL   (Japan)

^h OKAYAMA UNIVERSITY   (Japan)

ⁱ NAGOYA UNIVERSITY   (Japan)

^j HOKKAIDO UNIVERSITY   (Japan)

^k IWATE MEDICAL UNIVERSITY   (Japan)

^l SHINSHU UNIVERSITY   (Japan)

more..

Author keywords

Bromocriptine; Dopamine agonist; Levodopa; Parkinson s disease

Indexed keywords

AMANTADINE; BROMOCRIPTINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; LEVODOPA;

ADULT; AGED; AKINESIA; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DRUG CHOICE; DRUG EFFICACY; DYSKINESIA; FLAPPING TREMOR; GAIT; GASTROINTESTINAL SYMPTOM; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREMOR;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; BROMOCRIPTINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; GAIT; HUMAN; LEVODOPA; LONG-TERM CARE; MALE; MIDDLE AGE; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PROSPECTIVE STUDIES;

EID: 0026758669     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000116865     Document Type: Article

References (9)

1. Nakanishi T, Mizuno Y, Goto I, Iwaia M, Kanazawa I, Kowa H, Mannen T, Nishitani H, Ogawa N, Takahashi A, Tashiro K, Tohgi H, Yanagisawa N: A nationwide collaborative study on the long-term effects of bromocriptine in patients with Parkinson’s disease. First interim report in Japan. Eur Neurol 1988: 28(suppl l):3-8.
2. Nakanishi T, Iwata M, Goto I, Kanazawa I, Kowa H, Mannen T, Mizuno Y, Nishitani H, Ogawa N, Takahashi A, Tashiro K, Tohgi H, Yanagisawa N: Second interim report of the nationwide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients. Eur Neurol 1989: 29(suppl l):3-8.
3. Nakanishi T, Kanazawa I, Goto I, Iwata M, Kowa H, Mannen T, Mizuno Y, Nishitani H, Ogawa N, Takahashi A, Tashiro K, Tohgi H, Yanagisawa N: Third interim report of the nationwide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients. Eur Neurol 1990: 30(suppl I):3-8.
4. Nakanishi T, Mizuno Y, Goto I, Iwata M, Kanazawa I, Kowa H, Mannen T, Nishitani H, Ogawa N, Takahashi A, Tashiro K, Tohgi H, Yanagisawa N: A nationwide collaborative study on the long-term effects of bromocriptine in patients with Parkinson’s disease. Eur Neurol 1991.31 (suppl 1):3-I6.
5. Grimes JD, Delgado MR: Bromocriptine: Problems with low-dose de novo therapy in Parkinson’s disease. Clin Neuropharmacol 1985:8:73-77.
6. Hely MA, Morris JGL, Rail D, Rcid WGJ, O’Sullivan DJ, Williamson PM, Genge S: The Sydney multiccnter study of Parkinson’s disease: A report on the first 3 years. J Neurol Neurosurg Psychiatry 1989;52:324-328.
7. Lees AJ, Stern GM: Sustained bromocriptine therapy in previously untreated patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 1981:44:1020-1023.
8. Rascol A, Montastruc JL, Guiraud-Chaumeil B, Clanet M: La bromocriptine commc premier traitement de la maladie de Parkinson. Rev Neurol 1982:138:401-408.
9. Rinne UK: Early combination of bromocriptine and levodopa in the treatment for Parkinson’s disease. Lancet 1981:1:33.